Vaccine approvals add promise for COVAX use

Britain and Argentina authorized emergency use of a coronavirus vaccine that adds momentum to its anticipated global use by international organizations.

By Arete News - December 30, 2020

A registered nurse at the U.S. Naval Medical Center in San Diego administers a shot to a patient for the Phase III trial of AstraZeneca’s COVID-19 vaccine candidate (AN/Jake Greenberg)

You need to login to view this content. Please . Not a Member? Join Us

Vaccine nationalism hangs over 2021 recovery Richer countries locked up most of 2021's COVID-19 vaccine supply despite the COVAX Facility's multilateral…
Delays foreseen with COVAX vaccine deliveries International organizations acknowledged significant delays in delivering COVID-19 vaccines to poor nations due to pressure…
WHO urges end to bilateral vaccine deals The head of the U.N. health agency asked wealthy countries to stop hoarding most of…
WHO grants emergency use of China's Sinopharm WHO added a Chinese shot to its list of COVID-19 vaccines approved for emergency use,…
WHO adds vaccines for emergency use WHO listed two of AstraZeneca’s coronavirus vaccines for emergency use, only the second instance of…
COVAX vaccine rollout gets 2 billion doses The COVAX Facility has secured almost 2 billion doses of COVID-19 vaccine candidates for low-income…

Related Articles